Abstract
No public abstract is available from the verified source records.
Wenying Xu, Yin Ku, Guanyu Zhou, Jianqi Hao
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
openalex
Confidence 95%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Cancer treatment and survivorship statistics, 2019
2019
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018
Epidemiology of lung cancer
2019
Prognostic factors and prognostic staging system for small cell lung cancer
10.1093/jjco/27.3.158 · 1997
Nutritional status in the era of target therapy: poor nutrition is a prognostic factor in non-small cell lung cancer with activating epidermal growth factor receptor mutations
10.3904/kjim.2015.062 · 2016
Association between an inflammatory-nutritional index and nutritional status in cancer patients
2013
Cancer-related inflammation
10.1038/nature07205 · 2008
Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis
10.1093/ajcn/83.6.1345 · 2006
Association of preoperative serum CRP with PD-L1 expression in 508 patients with non-small cell lung cancer: a comprehensive analysis of systemic inflammatory markers
10.1016/j.suronc.2018.01.002 · 2018
datacite
Confidence 0%
The prognostic impact of neutrophil to lymphocyte ratio in advanced non-small cell lung cancer patients treated with EGFR TKI
10.2147/ijgm.s174605 · 2018
Prognostic value of neutrophil-to-lymphocyte ratio in patients with lung adenocarcinoma treated with radical dissection
2018
Peripheral blood markers predictive of outcome and immune-related adverse events in advanced non-small cell lung cancer treated with PD-1 inhibitors
10.1007/s00262-020-02585-w · 2020
Emerging blood-based biomarkers for predicting response to checkpoint immunotherapy in non-small-cell lung cancer
10.3389/fimmu.2020.603157 · 2020
Identification of biomarkers for non-small-cell lung cancer patients treated with an immune checkpoint inhibitor
10.21873/anticanres.14379 · 2020
Association of baseline peripheral-blood eosinophil count with immune checkpoint inhibitor-related pneumonitis and clinical outcomes in patients with non-small cell lung cancer receiving immune checkpoint inhibitors
10.1016/j.lungcan.2020.08.015 · 2020
Peripheral blood markers identify risk of immune-related toxicity in advanced non-small cell lung cancer treated with immune-checkpoint inhibitors
10.1634/theoncologist.2018-0563 · 2019
Correlations between peripheral blood biomarkers and clinical outcomes in advanced non-small cell lung cancer patients who received immunotherapy-based treatments
10.21037/tlcr-21-710 · 2021
Prognostic value of pre-treatment prognostic nutritional index in esophageal cancer: a systematic review and meta-analysis
10.3389/fonc.2020.00797 · 2020
The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis
10.1007/s00432-014-1714-3 · 2014
Prognostic value of pretreatment prognostic nutritional index in non-small cell lung cancer: a systematic review and meta-analysis
10.1177/1724600818799876 · 2018
Pretreatment prognostic nutritional index as a prognostic factor in lung cancer: review and meta-analysis
10.1016/j.cca.2018.08.030 · 2018
The relationship between nutritional status and prognosis in patients with locally advanced and advanced stage lung cancer
2021
Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European school of oncology task force
10.1093/annonc/mdu085 · 2014
Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment
10.1016/j.jhep.2012.08.017 · 2013
Neutrophil-lymphocyte ratio (NLR) predicted prognosis for advanced non-small-cell lung cancer (NSCLC) patients who received immune checkpoint blockade (ICB)
10.2147/ott.s199176 · 2019
Elevated pretreatment neutrophil/white blood cell ratio and monocyte/lymphocyte ratio predict poor survival in patients with curatively resected non-small cell lung cancer: results from a large cohort
10.1111/1759-7714.12454 · 2017
Prognostic significance of pre-operative monocyte-to-lymphocyte ratio in lung cancer patients undergoing radical surgery
10.1093/labmed/lmx069 · 2018
An elevated peripheral blood monocyte-to-lymphocyte ratio predicts poor prognosis in patients with primary pulmonary lymphoepithelioma-like carcinoma
2015
The relation between hemogram parameters and survival in extensive-stage small cell lung cancer
10.1159/000501595 · 2019
Prognostic significance of pre-resection albumin/fibrinogen ratio in patients with non-small cell lung cancer: a propensity score matching analysis
10.1016/j.cca.2018.04.012 · 2018
Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinum-based chemotherapy
10.1186/s12885-019-5490-y · 2019
Preoperative systemic immune-inflammation index predicts prognosis and guides clinical treatment in patients with non-small cell lung cancer
10.1042/bsr20200352 · 2020
Prognostic value of lymphocyte-to-monocyte ratio and systemic immune-inflammation index in non-small-cell lung cancer patients with brain metastases
10.2217/fon-2020-0423 · 2020
Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review
10.1186/1471-2407-13-158 · 2013
Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer
10.1186/s12967-017-1326-1 · 2017
Pretreatment Glasgow prognostic score and prognostic nutritional index predict overall survival of patients with advanced small cell lung cancer
2017
Clinical impact of pretreatment prognostic nutritional index (PNI) in small cell lung cancer patients treated with platinum-based chemotherapy
10.1111/crj.12925 · 2018
Comparison of the prognostic value of systemic inflammation response markers in small cell lung cancer patients
10.7150/jca.29319 · 2019
Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer
10.1186/s12957-015-0710-7 · 2015
Preoperative prognostic nutritional index as a predictor of outcomes in elderly patients after surgery for lung cancer
10.1093/jjco/hyy014 · 2018
The C-reactive protein/albumin ratio predicts long-term outcomes of patients with operable non-small cell lung cancer
10.18632/oncotarget.13053 · doi-reference
Exploration and validation of C-Reactive protein/albumin ratio as a novel inflammation-based prognostic marker in nasopharyngeal carcinoma
10.7150/jca.15401 · doi-reference
A novel inflammation-based prognostic score, the C-Reactive protein/albumin ratio predicts the prognosis of patients with operable esophageal squamous cell carcinoma
10.1371/journal.pone.0138657 · doi-reference
A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio
10.1186/s12885-015-1379-6 · doi-reference
Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib
10.4251/wjgo.v8.i7.555 · doi-reference
The C-reactive protein to albumin ratio predicts long-term outcomes in patients with pancreatic cancer after pancreatic resection
10.1007/s00268-016-3491-4 · doi-reference
The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer
10.1007/s13277-016-5122-y · doi-reference
Preoperative C-Reactive protein/albumin ratio predicts prognosis of patients after curative resection for gastric cancer
10.1016/j.tranon.2015.06.006 · doi-reference
The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma
10.1245/s10434-014-4048-0 · doi-reference
Evaluation of a modified early warning system for acute medical admissions and comparison with C-reactive protein/albumin ratio as a predictor of patient outcome
10.7861/clinmedicine.9-1-30 · doi-reference
Preoperative albumin level is superior to albumin-globulin ratio as A predicting indicator in gastric cancer patients who underwent curative resection
10.2147/cmar.s230741 · doi-reference
The prognostic role of preoperative serum albumin/globulin ratio in patients with non-metastatic renal cell carcinoma undergoing partial or radical nephrectomy
10.1038/s41598-020-68975-3 · doi-reference
Prognostic significance of pretreatment albumin/globulin ratio in patients with hepatocellular carcinoma
10.2147/ott.s109736 · doi-reference
Prognostic value of pretreatment albumin to globulin ratio in lung cancer: a meta-analysis
10.1080/01635581.2020.1737155 · doi-reference
Prognostic significance of immune-nutritional parameters for surgically resected elderly lung cancer patients: a multicentre retrospective study
10.1093/icvts/ivx337 · doi-reference
Prognostic nutritional index in gastrointestinal surgery
10.1016/0002-9610(80)90246-9 · doi-reference
Low advanced lung cancer inflammation index predicts poor prognosis in locally advanced nasopharyngeal carcinoma patients treated with definitive concurrent chemoradiotherapy
10.1155/2020/3127275 · doi-reference
Clinical significance of advanced lung cancer inflammation index, a nutritional and inflammation index, in gastric cancer patients after surgical resection: a propensity score matching analysis
10.1016/j.clnu.2020.07.018 · doi-reference
Prognostic value of advanced lung cancer inflammation index in head and neck squamous cell carcinoma
10.1007/s00405-019-05381-0 · doi-reference
The advanced lung cancer inflammation index predicts short and long-term outcomes in patients with colorectal cancer following surgical resection: a retrospective study
10.7717/peerj.10100 · doi-reference
Does advanced lung inflammation index (ALI) have prognostic significance in metastatic non-small cell lung cancer?
10.1111/crj.12768 · doi-reference
Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab-treated patients with advanced non-small cell lung cancer
10.1002/cam4.1234 · doi-reference
Prognostic role of the advanced lung cancer inflammation index in cancer patients: a meta-analysis
10.1186/s12957-019-1725-2 · doi-reference
The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer
10.1038/sj.bjc.6600466 · doi-reference
Preoperative monocyte-to-lymphocyte ratio in peripheral blood predicts stages, metastasis, and histological grades in patients with ovarian cancer
10.1016/j.tranon.2016.10.006 · doi-reference
Neutrophil to lymphocyte ratio is an independent prognostic factor in patients with recurrent or metastatic head and neck squamous cell cancer
10.3892/mco.2015.557 · doi-reference
Preoperative neutrophil-lymphocyte and lymphocyte-monocyte ratios reflect immune cell population rearrangement in resectable pancreatic cancer
10.1245/s10434-016-5634-0 · doi-reference
Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy
10.18632/oncotarget.8309 · doi-reference
Prognostic value of combination of preoperative platelet count and mean platelet volume in patients with resectable non-small cell lung cancer
10.18632/oncotarget.14921 · doi-reference
A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours
10.1016/j.suronc.2013.12.001 · doi-reference
Prognostic value of systemic immune-inflammation index in cancer: a meta-analysis
10.7150/jca.25691 · doi-reference
Prognostic nutritional index and systemic immune-inflammation index predict the prognosis of patients with HCC
10.1007/s11605-019-04492-7 · doi-reference
Prognostic significance of systemic immune-inflammation index in triple-negative breast cancer
10.2147/cmar.s197623 · doi-reference
The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma
10.1002/jcp.27052 · doi-reference
Systemic immune-inflammation index, based on platelet counts and neutrophil-lymphocyte ratio, is useful for predicting prognosis in small cell lung cancer
10.1620/tjem.236.297 · doi-reference
Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma
10.1158/1078-0432.ccr-14-0442 · doi-reference
Albumin-to-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals
10.1002/cam4.1428 · doi-reference
Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells
10.1182/blood.v96.10.3302 · doi-reference
Prognostic role of pretreatment plasma D-Dimer in patients with solid tumors: a systematic review and meta-analysis
10.1159/000487734 · doi-reference
Prognostic significance of the lymphocyte-to-monocyte ratio in patients with malignant pleural mesothelioma
10.1016/j.lungcan.2015.07.014 · doi-reference